GSK, Yale Enter Drug Discovery Collaboration
May 3, 2012
May 3, 2012 | GlaxoSmithKline and Yale have entered a new drug discovery partnership focused on potential medications to target disease-causing proteins. A joint research team will work on Yale's existing PROTAC technology or proteolysis targeting chimeric molecules. Hartford Business Journal